U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H25BrF2O5
Molecular Weight 475.321
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HALOPREDONE

SMILES

[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@@H](F)C4=CC(=O)C(Br)=C[C@]34C

InChI

InChIKey=MYZDPUZXMFCPMU-LRIWMWCYSA-N
InChI=1S/C21H25BrF2O5/c1-18-8-16(27)21(24)11(10(18)3-4-20(18,29)17(28)9-25)5-14(23)12-6-15(26)13(22)7-19(12,21)2/h6-7,10-11,14,16,25,27,29H,3-5,8-9H2,1-2H3/t10-,11-,14+,16-,18-,19-,20-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H25BrF2O5
Molecular Weight 475.321
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/341904

Halopredone (THS-201; (17,21-bis(acetyloxy)-2-bromo-6beta,9-difluoro-11beta-hydroxypregna-1,4-diene-3,20-dione; halopredone acetate; Topicon) is a highly topical corticosteroid. When it is used for intraarticular injections, the effects last longer than any other steroids which have been used, and it has less general effects. Halopredone acetate is used for arthritis and osteoarthritis (OA) patients. For RA patients, mean dose for a wrist is 12.5 mg and that for a knee is 25 mg. About 90% cases showed effectiveness and in about 45% cases the duration of effect is longer than 4 weeks. More than half cases of OA showed also improvements. It also possesses positive anti-inflammatory properties in dermatologic patients.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

In Vivo Use Guide
for rats: locally: 80 micrograms/pellet s.c.: 100 mg/kg
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 18:33:29 GMT 2023
Edited
by admin
on Fri Dec 15 18:33:29 GMT 2023
Record UNII
6F4361R42W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HALOPREDONE
INN   WHO-DD  
INN  
Official Name English
halopredone [INN]
Common Name English
PREGNA-1,4-DIENE-3,20-DIONE, 2-BROMO-6,9-DIFLUORO-11,17,21-TRIHYDROXY-, (6.BETA.,11.BETA.)-
Systematic Name English
Halopredone [WHO-DD]
Common Name English
Code System Code Type Description
WIKIPEDIA
Halopredone
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
NCI_THESAURUS
C166933
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
CAS
57781-15-4
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
ChEMBL
CHEMBL2106520
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
EPA CompTox
DTXSID901024141
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
EVMPD
SUB08006MIG
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
INN
4077
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
PUBCHEM
12788355
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
FDA UNII
6F4361R42W
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
ECHA (EC/EINECS)
260-953-5
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
SMS_ID
100000083925
Created by admin on Fri Dec 15 18:33:29 GMT 2023 , Edited by admin on Fri Dec 15 18:33:29 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY